|
|
Article: TARGETED GENETICS FORMS SPIN-OFF COMPANY FOR CELL THERAPY ASSETS.(Brief Article)
- Article from:
- BIOWORLD Today
- Article date:
- November 9, 2000
- Author:
CopyrightCOPYRIGHT 2000 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Targeted Genetics Corp. is doing what was once done to it - spinning out a wholly owned subsidiary with plans to let it go further as it grows.
Targeted Genetics, a spin-off itself from Immunex Corp., said it will package its cell-therapy related assets and intellectual property into CellExSys, making the announcement in conjunction with its presentation Wednesday at the Techvest LLC Second Annual Conference on Tissue Repair, Replacement and Regeneration in New York City.
"This intellectual property came in with us and, as the in vivo technology evolved, Targeted Genetics has focused on that," said Stephanie Seiler, director of communications at ...